Discontinued Operations (Details) (USD $)	12 Months Ended
	Dec. 31, 2013		Dec. 31, 2012		Dec. 31, 2007
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners	32.00%
Other Asset Impairment Charges			$ 700,000
Disposal Group, Including Discontinued Operation, Income Statement Disclosures [Abstract]
Asset Impairment Charges	0		23,517,000
Facilities realignment	0		706,000		1,000,000
Severance Costs	0		0
Liabilities Subject to Compromise, Period Increase (Decrease) [Roll Forward]
Accrued Liability at beginning of the period	5,000	[1]	1,120,000
Add: Costs incurred, excluding non-cash charges	0		0
Payments for Postemployment Benefits	(5,000)		(1,115,000)
Accrued Liability at end of the period	0	[1]	5,000	[1]
Net Income (Loss) Attributable to Parent [Abstract]
Revenue, net	0		0
Loss from discontinued operations, before income tax	(44,000)		(51,000)
Income tax expense	5,000		8,000
Loss from discontinued operations, net of tax	(49,000)		(59,000)
Disposal Group, Including Discontinued Operation, Classified Balance Sheet Disclosures [Abstract]
Current assets	0		14,000
Non-current assets	150,000		150,000
Total assets	150,000		164,000
Current liabilities	405,000		368,000
Non-current liabilities	619,000		1,006,000
Total liabilities	$ 1,024,000		$ 1,374,000

[1] Accrued liability at December 31, 2012 consists of Pharmakon employee severance costs.